Acute Coronary Syndrome
Conditions
Interventions
1:Taking Danlou Tablets Capsule
2:Taking Placebo
Sponsors
Guangdong Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Consistent with acute coronary syndrome (including unstable angina and non-ST elevation myocardial infarction) in the diagnosis; 2. TCM is Qi phlegm Permit; 3. Aged 18 to 80 years old; 4. Agree coronary intervention; 5. Did not take Statins within recent 2 weeks; 6. Able and willing to provide signed informed consent.
Exclusion criteria
Exclusion criteria: 1. ST-segment elevation myocardial infarction; 2. High-risk non-ST-segment elevation myocardial infarction, patients who required emergent PCI; 3. Severe damage to liver and kidney function (serum alanine aminotransferase> 3 times the upper limit of normal and / or serum creatinine levels >=265umol/L); 4. Severe blood system, nervous system diseases and cancer patients; 5. Cardiogenic shock; 6. With severe heart failure (Class IV heart function, or left ventricular ejection fraction <=30%); 7. Pregnant or lactating women; 8. Patients who participate in other researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cTnI;High-sensitivity-CRP;CK;CK-MB;major adverse cardiavascular events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Coronary heart disease Integrative quality of life table;TCM Syndrome Evaluation Table;Seattle Angina Scale; | — |
Countries
China
Contacts
Public ContactMinzhou Zhang
Outcome results
None listed